Cite
APA Citation
Rossi, S., Motta, C., Studer, V., Boffa, L., De Chiara, V., Castelli, M., Barbieri, F., Buttari, F., Monteleone, F., Germani, G., Macchiarulo, G., Weiss, S., & Centonze, D. (2014). treatment Options to Reduce Disease Activity After Natalizumab: Paradoxical Effects of Corticosteroids. CNS neuroscience & therapeutics, 20, 748–753. http://access.bl.uk/ark:/81055/vdc_100024884086.0x00000e